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Background: Cyclic Cushing’s disease (CD) has been described in about 15% of
adult patients with CD. In the pediatric population, diagnosis of CD is rare and cyclic
presentations of the disease are not adequately understood or described. Moreover,
prepubertal patients usually do not present with the typical signs and symptoms of CD,
which can obscure or delay diagnosis. In this paper, we report a case of cyclic CD in a
prepubertal age girls whose etiology was a pituitary corticotropinoma.
Case presentation: A Caucasian 7.8 year old girl was admitted to pediatric
endocrinology for the evaluation of short stature and prior obesity. The patient remained
overweight despite significant lifestyle modifications, resulting in 6 kg weight loss during
the prior 6 months. The physical exam was notable for precocious adrenarche and
thelarche, but difficult to differentiate from steatomastia. Hypothalamo-pituitary-adrenal
axis diagnostics, including single diurnal excretion of urinary cortisol, morning ACTH, and
serum cortisol levels, were all within normal limits, and MRI of the pituitary gland showed
no deviations at this time. Because of the clinical suspicion of cyclic hypercortisolemia,
she was referred to our outpatient clinic for follow-up. After 6 months, the patient
returned with rapid weight gain, accompanied by nocturnal anxiety, exacerbation of
depressive behavior, insomnia and excessive sweating, and was readmitted to the
ward for testing. Standard diagnostics confirmed CD and repeat MRI at 8.6 years
old showed a microadenoma of 3 × 4mm in the right side of the anterior pituitary
gland. Histopathologic examination described an atypical, densely-granulated pituitary
corticotroph adenoma with Ki-67 expression above 3%.
Conclusion: Cyclic presentations of CD in the prepubescent age group could cause
difficulties in diagnosis because of atypical signs and symptoms, which can be absent
in the remission phase. Decreases in height percentiles and velocities obtained from the
growth chart, as well as fluctuations in weight, and signs of androgenization can allow
the clinician to suspect cycling CD in prepubertal patients. Confirmation of cyclic CD
diagnosis is only possible during periods of relapse (hypercortisolemic state) and should
be investigated according to the current diagnostic standard.
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BACKGROUND
Cushing’s syndrome (CS) caused by an excess pituitary
production of adrenocorticotropic hormone (ACTH) is
referred to as Cushing’ disease (CD), and is a rare disorder in
prepubertal children. Moreover, CD which occurs cyclically
is much less frequent, with unknown incidence in childhood.
In children younger than 7 years, ACTH-independent causes
of hypercortisolemia, primarily adrenal carcinoma, are more
frequently seen than ACTH-dependent ones (1). According
to recent data, after the age of 5 years ACTH-dependent
CS is more common than ACTH-independent CS. In most
cases, ACTH is produced by a pituitary microadenoma (2).
The overproduction of ACTH occurs in a semi-autonomous
manner and retains some auto-regulatory properties of the
hypothalamic-pituitary-adrenal axis in the negative feedback
cycle (3). In children, overproduction of ACTH causes
hypercortisolemia resulting in obesity (BMI ≥ 1.5 SD) with
simultaneous growth inhibition (growth velocity ≤ 0 SD),
behavioral changes, and hyperandrogenization (hirsutism,
precocious puberty without regression due to the suppression
of gonadal axis by adrenal androgens). There are no symptoms
of excess aldosterone (4). The prepubertal child with CD
may present with obesity and growth failure alone, without
other classical features such as plethora, hirsutism, acne, and
striae (5).
Cyclic CS is characterized by repeated episodes of cortisol
excess (relapses) interspersed by periods of normal cortisol
secretion (remissions). The so-called cycles of hypercortisolism
can occur regularly or irregularly with intercyclic phases ranging
from days to years. Cycle lengths between 12 h and 85 days
have been reported (6). Cyclic CS originates in 54% of cases
from a pituitary corticotroph adenoma, in 26% from an ectopic
ACTH-producing tumor and in about 11% from an adrenal
tumor, the remainder being unclassified (7). To formally diagnose
cyclic CS, three peaks and two troughs of cortisol production
(clinical and/or biochemical) should be demonstrated, separated
in time by intercyclic phases. The majority of patients with
cyclic CS have clinical signs of CS, which can be either
fluctuating or permanent. In a minority of patients, clinical
signs of CS are absent. The fluctuating clinical picture and
discrepant biochemical findings render cyclic CS extremely hard
to diagnose. Clinicians should therefore be aware of this clinical
entity and actively search for it in all patients with suspected
CS but normal biochemistry or vice versa (7). Therefore, strict
observation and repeated measurement of urinary cortisol are
a reliable and convenient screening tool for suspected cyclic
CS (8).
We present the case of a 7.8 year old girl whose symptoms
of CS began in the pre-pubertal period and were cyclic. Her
parents gave their written, informed consent for the presentation
of the medical data and her photos in the journal article.
Our national guidelines waived the requirement for ethical
approval for the presentation of patients’ medical data by the
leading doctor.
CASE REPORT
A 7.8 year old Caucasian girl was brought by her mother
to pediatric endocrinology due to short stature and excess of
body mass. Upon the first visit the patient was in good clinical
condition. Her height was 114 cm (below 3rd percentile) and
her body weight was 24 kg (+14.7% excess of body weight
appropriate for her height, and BMI 18.5 kg/m2, 87th percentile,
Z-score 1.12). According to her mother, the patient had been
obese 6 months prior but had lost 6 kg within the last 6 months
due to dietary changes and lifestyle modification. The mother
was also worried that the child was always the shortest in the
peer group since kindergarten. The patient’s growth curve was
compiled from measurements reported in her medical records
and showed that her growth was linear along the 3rd percentile
during the past year, but a previous available measurement
performed in the 2nd year of life was at the 25th percentile.
Her mid-parental height (MPH) was between the 50th and 75th
percentiles (Figure 1). Moreover, signs of precocious puberty
were noticed: pubarche II stage according to Tanner scale without
axillarche, and doubtful thelarche difficult to differentiate from
steatomastia. Therefore, the girl was admitted to the ward for
further diagnostics.
Sampling of urinary-free cortisol (UFC) in one 24 h
urine collection, morning serum ACTH, cortisol, and 17-
OHP concentrations were normal. GnRH stimulation test was
performed and did not confirm central precocious puberty.
Ultrasonography of the abdomen was normal. MRI of the
hypothalamic-pituitary area was performed at the age of 8
and showed no deviations. However, because of a suspicion
of potential cyclic hypercortisolemia [thanks to our previous
experience with primary pigmented nodular adrenocortical
disease (PPNAD) patients] the decision of a further follow-up
observation was made.
After 6 months, the patient returned with rapid weight
gain and darkening of her skin, accompanied by nocturnal
anxieties, exacerbation of depressive behavior, insomnia, and
excessive sweating. She was therefore admitted to the ward
for re-evaluation of the hypothalamo-pituitary-adrenal axis and
to repeat the MRI of the hypothalamic-pituitary area. At 8.6
years, +57% excess body weight to height was visible, BMI was
23.6 kg/m2 (97 percentile, +5.8 SD, Z-score 2.46). Retrospective
analysis of her growth chart showed inhibition of her growth
velocity during last 3 years from 25 percentile to −2.4 SD,
with rapid development of obesity (only during last year from
+9% to +57%), varying in time (Figure 2). The photos of the
girl presented by her mother revealed cyclic changes of her
appearance in previous several months (Figure 3). At admission
the girl was sad and depressive. Obesity was visible mainly on her
face, neck, and abdomen, with areas of acanthosis nigricans on
her neck (Figure 3), hirsutism on her back, thighs and above her
upper lip. She presented with pubarche (II stage) in the absence of
development of the breast glands (steatomastia). Blood pressure
was normal. Bone age was in line with her chronological age of
8 years.
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FIGURE 1 | Growth chart of the patient with cyclic Cushing’s disease.
Because of the suspicion of CD, the diagnostic process was
provided based on standard hormonal criteria: increased UFC
in three 24 h urine collections, disturbances of cortisol circadian
rhythm, increased or not suppressed plasma ACTH levels at 8.00
am accompanying increased serum cortisol levels, and a failure to
suppress serum cortisol levels to <1.8 µg/dl during an overnight
dexamethasone suppression test (ODST; 1mg of dexamethasone
was given at 11.00 pm). The pituitary etiology of CS was
confirmed based on the serum cortisol suppression in a high-dose
dexamethasone suppression test (2mg q.i.d. for 48 h), a positive
result of a corticotropin-releasing hormone (CRH) stimulation
test (1 µg/kg, maximum 100 µg i.v.) and positive pituitary MRI.
The above diagnostics have shown hypercortisolemia. Diurnal
collection of UFC exceeded 10-fold the normal range [219, 284,
and 283 µg/24 h respectively, normal range (N) <27 µg/24 h].
The temporal cortisolemic profile was reversed and without a
night-time decline (8.00 a.m.−9.5 µg/dl, 8.00 p.m. −18.5 µg/dl,
midnight −25.4 µg/dl). The ACTH concentration at the same
time was 37.9 pg/ml (N 10–60 pg/ml), ruled in ACTH-dependent
CS (no suppression (>20 pg/ml) with hypercortisolemia). Plasma
renin activity (1.57 ng/ml/h, N 1.5 −5.7), aldosterone (85.4
pg/ml, N 35 −310), DHEA-S (36.5µg/ml N <150) were within
normal limits. After ODST, cortisol levels decreased (from 9.5
to 1.02 µg/dl) whereas the ACTH level was stable (34.2 pg/ml).
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FIGURE 2 | Body mass chart of the patient with cyclic Cushing’s disease.
The result of CRH stimulation test then confirmed CD with an
increase in ACTH by 46% (>35%) and cortisol by 45% (>20%).
MRI of the pituitary, repeated 6 months after the previous, which
was normal, revealed an area of reduced signal that measured 3
× 4mm located in the right-sided part of the anterior pituitary
gland (Figure 4).
After pharmacological preparation (ketoconazole), the patient
underwent an endoscopic transsphenoidal resection of the
pituitary microadenoma. The histopathological examination
revealed an atypical, densely-granulated pituitary corticotroph
adenoma. The level of MIB1 antibodies, used to measure Ki-
67 expression, was above 3%. Neurosurgery treatment resulted
in the resolution of endogenous hypercortisolemia. The patient
required hydrocortisone supplementation for 4 months after
surgery. MRI of the pituitary gland performed 3 and 12 months
after surgery, revealed postoperative changes, without tumor
regrowth. Currently, one and a half years after surgery, her BMI
is 21.7 kg/m2 (92th percentile, 1.42). The rate of her growth has
improved (current height is between 10 and 25th percentiles).
On exam, there are no symptoms of hypercortisolemia. All
biochemical tests, assessing her hormonal axes were normal
at 1 year.
Analysis of the clinical picture of the patient and the results
of the tests performed in the hypercortisolemic (relapse) period
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indicated a diagnosis of cyclic CD (cyclic ACTH-dependent
CS) induced by pituitary microadenoma, which was confirmed
by histopathological examination, after a transsphenoidal
tumor resection.
DISCUSSION
We present a case of cyclic CD in the prepubertal period.
According to our knowledge, it is the first such description in
medical literature. Both conditions, cyclic CD as well as CD,
in prepubertal time are very rare in medical practice. Only
several cases of cyclic CS in children have been described in
prepubertal time. PPNAD and hyperplasia of adrenocoticotrophs
were causes of cyclicity of CS in some reports (9, 10). However,
one case of prepubertal cyclic CD was described (11), but the
diagnosis is unclear. There was a boy who at the age of 4
FIGURE 3 | Pictures of the patient with cyclic Cushing’s disease in
symptomatic hypercortisolemia at the age 7 2/12 years, followed by remission
at the age 7 8/12 years and in the relapse period at the age 8 6/12 years.
started sudden, unexplained weight gain and for almost 8 years
presented with several episodes of facial and abdominal swelling
with concomitant hypertension, but without deterioration of his
growth velocity, which occurred finally at the age of 12. At
that time, in spite of repeated hypercortisolemia as displayed
previously, ACTH level was periodically elevated. Computerized
tomography suggested a filling defect in the pituitary and finally a
basophil pituitary adenoma was removed. This patient at the age
of 5.5 had a left atrial myxoma removed, and together with the
repeated episodes of hypercortisolemia should suggest PPNAD
in Carney complex (12). In the outcome of PPNAD, ACTH
fluctuation could be also observed. There is no information
about further outcome of the disease after neurosurgery in the
described patient.
The most numerous group of cyclic CD was described by
Alexandraki et al. (13). In the cited study, cyclicity was considered
as the presence of at least one cycle, defined as a clinical
and/or biochemical hypercortisolaemic peak followed by clinical
and biochemical remission, followed by a new clinical and/or
biochemical hypercotisolaemic peak. According to this definition
our patient fulfills its criteria. Our patient could have been
diagnosed with the cyclic form of the CD after just one cycle
confirmed clinically and biochemically. The cycle lasted about
1 year. However, because of atypical signs and syndromes of
CD in prepubertal time, we cannot be sure if more previous
hypercortisolemia periods could have taken place before this
one cycle described and confirmed clinically by the patient’s
mother, photos, and the analysis of patient’s growth chart. Due
to the insidious course of the disease and various long periods of
remission and relapse, diagnosis usually lasts up to several years
(6). The cyclical, insidious clinical course and atypical signs and
symptoms of CD in prepubertal periodmay be responsible for the
difficulties of its diagnosis. The knowledge of this phenomenon
is important because, if not recognized, it can lead to failure in
diagnosis of the disease. Significant cortisol fluctuations in CS
FIGURE 4 | MR image of the hypothalamic-pituitary area with contrast with visible pituitary adenoma in the patient with cyclic Cushing’s disease in the second relapse
period (clinical and biochemical hypercortisolemia at the age of 8 6/12 years).
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were first recognized in 1956 by Birke et al. (14). However, the
first description of cyclic CS is usually ascribed to Bailey who
published another case in 1971 (15). He presented evidence for
cycles of production in a patient with a slow-growing malignant
lung tumor (carcinoid type). Since that time there were further
sporadic and rare reports of this type of CS described. In the
study of Alexandraki et al. who analyzed CD patients treated
from 1946 to 2007 and described cyclicity in 30 (14.9%, 26
females) of them (13), the median number of cycles was two for
each patient, and 4 years was the median intercyclic period. In
multivariate analysis older patients, longer follow-up, female sex,
and no histological identification of the adenoma were associated
with an increased risk of cyclic disease. However, the study was
retrospective and relied totally on patient recall of the clinical
situation, and the reports by the physicians in the medical case
records. In this long-time of observation different diagnostic
methods were also used to diagnose CS. In this study only one
of the 17 pediatric patients (5.88%) showed cyclicity, but detailed
data about their age were not presented. Due to the periods of
relapse and remission of the disease lasting variously for a long
time (and thus diagnostic difficulties), the incidence of the disease
is considered to be underestimated.
Atkinson’s team also described some cases of cyclic CD
diagnosed postoperatively, after transsphenoidal microsurgery
for CD (16). The authors of this observation suggest that
cyclic CD may be a much more common finding than
previously recognized and emphasized the need for detailed and
ongoing endocrinological investigation after pituitary surgery
for hypercortisolism.
There is also an abstract presenting refractory cyclical CD
diagnosed first time in a 3.8 year old girl in whom the whole
anterior pituitary gland was removed and a relapse of CD
occurred 6 years after surgery (17). The description of this case in
our opinion indicate rather a relapse of non-cyclic CD following
treatment, which has been reported in about 10–30% of patients
with CD after neurosurgery (18, 19).
The pathophysiology of cyclic CS is largely unknown. One
known cause of cyclic CS in childhood is PPNAD which
is ACTH-non-dependent CS, moreover patients with PPNAD
could present with other concomitant diseases (9, 12, 20).
Several hypotheses have been suggested to explain cyclicity of
CD, including episodic hemorrhage, the synchronous growth
and death of tumor cells (7, 21) or fluctuations in adrenal-
pituitary axis feedback (22). Nevertheless, the regularity of
cyclic CD is difficult to explain by fluctuating cell growth
and death only (7). Another theory supposes a hypothalamic
origin for cyclic CD, with periodic changes in neurotransmitters
contributing to pituitary ACTH secretion being involved. These
neurotransmitters include CRH, noradrenaline, dopamine,
acetylcholine, and gamma-aminobutyric acid. To summarize,
ACTH secretion by a pituitary tumor could be regulated through
autocrine or paracrine mechanisms, and lead to the long-term
cycling seen in a fraction of CD cases.
In our case, the patient presented with CD symptoms in
prepubertal time, and the diagnosis of cyclical CD was made
at the age 8.5 years. There are no data about cyclic CD in
childhood in the literature to compare with ours. The median
age of CD diagnosis in children is 14.1 years old (23). The
occurrence of such a rare disorder at such an early age may
suggest a genetic basis of the disease. According to the latest
literature, some mutations may play a role in the pathogenesis
of Cushing’s disease. In more than one-third of patients under
the age of 18 years with CD, somatic ubiquitinase gene 8 (USP8)
mutations were identified (24). The USP8 gene encodes a protein
(with deubiquitinase activity) that inhibits lysosomal degradation
of the epidermal growth factor receptor (EGFR), which in turn
leads to increased expression of POMC and production of ACTH
(25, 26). Another gene predisposing to corticotropinomas is
CABLES1 (27). Mutations in this gene have been found in both
children and adults with corticotropinoma. Genetic processes
leading to CD are still not fully understood. Further research into
the genetic background may allow us to identify the causes of
CD and may be the basis for new therapeutic methods, especially
in patients with cyclic outcomes of the disease. Therefore,
the presented patient is an excellent candidate for potential
genetic testing.
When cyclic CS is biochemically confirmed in childhood,
further imaging, and laboratory studies are guided by the
presence or absence of ACTH dependency. Suppressed ACTH
levels suggest that the disease is located in the adrenal gland
(PPNAD, hyperplasia, other tumors) and diagnostics should be
directed toward these diseases (9). In cases of suspected ectopic
ACTH production, specific biochemical testing for carcinoids
or neuroendocrine tumors is required, including measurements
of serotonin in platelets and/or urine, chromogranin A, and
calcitonin. Differential diagnosis of cyclic CS should include
following conditions: mild and subclinical CS, pseudo-Cushing’s
states, aberrant receptor mediates CS, factitious CS, and
glucocorticoid resistance (7). All above-mentioned conditions
were excluded in the presented case.
Although CD is the most common case of CS in childhood, in
prepubertal age children, it is very rare and presents an important
diagnostic and therapeutic challenge. Dias et al. presented 17
prepubertal children, with predominance of males (13M, 4F). All
children had below normal linear growth and excessive weight
gain at presentation. A high proportion (85% of males, 75%
of females) had evidence of excessive virilization. Striae and
hypertension were seen in 41% of patients (5). The difficulties
associated with the clinical, biochemical, and radiological
diagnosis of Cushing’s disease in children are known and have
been described before. Early diagnosis remains a challenge
because test results often do not match standard diagnostic
criteria (28, 29). The investigation of highest sensitivity (100%)
for CD was excessive increase of serum cortisol to intravenous
CRH (mean increase 113%) (5). Visualization of the pituitary
microadenoma in MRI is not necessary for the diagnosis of
CD, because tumors <3–4mm in size are only found in about
half of the cases. In two studies including pediatric patients,
pituitary adenomas were found in 63 and 55% (18, 30). In our
patient, the first MR image of the pituitary was normal but the
next MRI (half a year later) showed a pituitary microadenoma.
Although we did not perform bilateral inferior petrosal sinus
sampling, this procedure can be more sensitive than pituitary
imaging in localization of microadenomas and has been
associated with improved cure rate by transsphenoidal selective
adenomectomy (31).
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CONCLUSION
The cyclic clinical course and atypical signs and symptoms of CD
in prepubertal period, may be responsible for the difficulties in
diagnosis and its insidious outcome. The knowledge about this
phenomenon is very important for the pediatrician to avoid long-
term complications of failing to recognize Cushing’s Disease and
its consequences for the future health of the child.
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